Sort   by:  
 Page size 
UnknownBIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
Not available
S-EPMC4671004 | biostudies-literature
UnknownImmunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes.
Not available
S-EPMC12645730 | biostudies-literature
UnknownRisk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study.
Not available
S-EPMC10119842 | biostudies-literature
UnknownThe first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant.
Not available
S-EPMC8481935 | biostudies-literature
UnknownRisk levels for suffering a traffic injury in primary health care. The LESIONAT project.
Not available
S-EPMC2851683 | biostudies-literature
UnknownCorticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.
Not available
S-EPMC7095489 | biostudies-literature
UnknownMural Endocarditis: The GAMES Registry Series and Review of the Literature.
Not available
S-EPMC8572950 | biostudies-literature
UnknownEffect of Direct Transportation to Thrombectomy-Capable Center vs Local Stroke Center on Neurological Outcomes in Patients With Suspected Large-Vessel Occlusion Stroke in Nonurban Areas: The RACECAT Randomized Clinical Trial.
Not available
S-EPMC9073661 | biostudies-literature
UnknownOutpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria.
Not available
S-EPMC9512706 | biostudies-literature
UnknownCharacteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.
Not available
S-EPMC7399713 | biostudies-literature
Sort   by:  
 Page size